First-in-class antibody-drug conjugate shows significant clinical benefit against met [Archive]

View Full Version : First-in-class antibody-drug conjugate shows significant clinical benefit against met

News

11-08-2015, 10:14 AM

IMMU-132, an anti-Trop-2 antibody-drug conjugate (ADC) was safe, tolerable,and yielded meaningful clinical activity in heavily pretreated patients with metastatic triplenegativebreast cancer...

More... (http://www.medicalnewstoday.com/releases/302233.php)